The Economist @TheEconomist
The current trial-and-error approach to prescribing antidepressants means they only offer large benefits in 15% of cases. Scientists hope new data-driven methods will be more effective https://t.co/sWvDszpwqj https://t.co/MC37hv1Kpm — PolitiTweet.org